Press "Enter" to skip to content

New patent expiration for Gilead drug TRUVADA

1
Copyright © DrugPatentWatch. Originally published at New patent expiration for Gilead drug TRUVADA

Annual Drug Patent Expirations for TRUVADA
Annual Drug Patent Expirations for TRUVADA

Truvada is a drug marketed by Gilead and is included in one NDA. It is available from seven suppliers. There are six patents protecting this drug and two Paragraph IV challenges.

TRUVADA drug price trends.

Drug patent litigation for TRUVADA.

This drug has fifty-nine patent family members in twenty-nine countries.

The generic ingredient in TRUVADA is emtricitabine; tenofovir disoproxil fumarate. Seven suppliers are listed for this compound. Additional details are available on the emtricitabine; tenofovir disoproxil fumarate profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

Get the Daily Briefing or Try a trial

Copyright © DrugPatentWatch. Originally published at New patent expiration for Gilead drug TRUVADA
Get the DrugPatentWatch Daily Briefing

✓ Patent Expirations and Generic Entry

✓ Insightful Articles & Case Studies

✓ Patent Litigation & Challenges

✓ 505(b)(2) & Biosimilars

✓ Industry Trends

DrugPatentWatch - Make Better Decisions